142 related articles for article (PubMed ID: 6144550)
1. The chemical basis for the blockade of the D-1 dopamine receptor by SCH 23390.
Itoh Y; Beaulieu M; Kebabian JW
Eur J Pharmacol; 1984 Apr; 100(1):119-22. PubMed ID: 6144550
[TBL] [Abstract][Full Text] [Related]
2. Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390.
Hyttel J
Neuropharmacology; 1984 Dec; 23(12A):1395-401. PubMed ID: 6152023
[TBL] [Abstract][Full Text] [Related]
3. [125I]SCH 23982: the ligand of choice for identifying the D-1 dopamine receptor.
Sidhu A; van Oene JC; Dandridge P; Kaiser C; Kebabian JW
Eur J Pharmacol; 1986 Sep; 128(3):213-20. PubMed ID: 2947806
[TBL] [Abstract][Full Text] [Related]
4. Relative activities of SCH 23390 and its analogs in three tests for D1/DA1 dopamine receptor antagonism.
Barnett A; Ahn HS; Billard W; Gold EH; Kohli JD; Glock D; Goldberg LI
Eur J Pharmacol; 1986 Sep; 128(3):249-53. PubMed ID: 2878816
[TBL] [Abstract][Full Text] [Related]
5. Absence of D1 dopamine receptors that stimulate prolactin release in the rat pituitary.
Cocchi D; Ingrassia S; Rusconi L; Villa I; Müller EE
Eur J Pharmacol; 1987 Oct; 142(3):425-9. PubMed ID: 2962879
[TBL] [Abstract][Full Text] [Related]
6. The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats.
Imperato A; Mulas A; Di Chiara G
Eur J Pharmacol; 1987 Oct; 142(1):177-81. PubMed ID: 2891544
[TBL] [Abstract][Full Text] [Related]
7. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
Makman MH; Dvorkin B
Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
[TBL] [Abstract][Full Text] [Related]
8. SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.
Breese GR; Mueller RA
Eur J Pharmacol; 1985 Jul; 113(1):109-14. PubMed ID: 2864260
[TBL] [Abstract][Full Text] [Related]
9. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological evaluation of SCH-12679: evidence for an in vivo antagonism of D1-dopamine receptors.
Breese GR; Criswell HE; McQuade RD; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1990 Feb; 252(2):558-67. PubMed ID: 1968972
[TBL] [Abstract][Full Text] [Related]
11. A study on the contribution of the 1-phenyl substituent to the molecular electrostatic potentials of some benzazepines in relation to selective dopamine D-1 receptor activity.
Pettersson I; Gundertofte K; Palm J; Liljefors T
J Med Chem; 1992 Feb; 35(3):502-7. PubMed ID: 1531365
[TBL] [Abstract][Full Text] [Related]
12. Structural determinants of selective affinity for brain D-1 dopamine receptors within a series of 1-phenyl-1H-3-benzazepine analogues of SK&F 38393 and SCH 23390.
O'Boyle KM; Waddington JL
Eur J Pharmacol; 1985 Sep; 115(2-3):291-5. PubMed ID: 2866103
[TBL] [Abstract][Full Text] [Related]
13. Structural analogs of SCH 23390 as discriminators of dopamine receptor subtypes: behavioral interactions between D-1 and D-2 agonists and antagonists.
O'Boyle KM; Molloy AG; Mashurano M; Waddington JL
Psychopharmacol Bull; 1986; 22(3):599-604. PubMed ID: 2879303
[No Abstract] [Full Text] [Related]
14. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.
Briggs CA; Pollock NJ; Frail DE; Paxson CL; Rakowski RF; Kang CH; Kebabian JW
Br J Pharmacol; 1991 Dec; 104(4):1038-44. PubMed ID: 1687364
[TBL] [Abstract][Full Text] [Related]
15. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.
Iorio LC; Barnett A; Leitz FH; Houser VP; Korduba CA
J Pharmacol Exp Ther; 1983 Aug; 226(2):462-8. PubMed ID: 6135795
[TBL] [Abstract][Full Text] [Related]
16. Repeated administration of (-)sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions.
Memo M; Pizzi M; Nisoli E; Missale C; Carruba MO; Spano P
Eur J Pharmacol; 1987 Jun; 138(1):45-51. PubMed ID: 2887436
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of SCH 23390-induced alteration of striatal dopamine D1 receptor ontogeny by prolyl-leucyl-glycinamide in the rat.
Kostrzewa RM; Saleh MI
Neuropharmacology; 1989 Aug; 28(8):805-10. PubMed ID: 2571103
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
Rosenzweig-Lipson S; Bergman J
J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
[TBL] [Abstract][Full Text] [Related]
19. Radiosynthesis of a selective dopamine D-1 receptor antagonist: R(+)-7-chloro-8-hydroxy-3-[11C]methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3 -benzazepine ([11C]SCH 23390).
Ravert HT; Wilson AA; Dannals RF; Wong DF; Wagner HN
Int J Rad Appl Instrum A; 1987; 38(4):305-6. PubMed ID: 3040632
[TBL] [Abstract][Full Text] [Related]
20. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
Monti JM; Fernández M; Jantos H
Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
